Why the study?
The effectiveness of cardiovascular risk stratification using the SCORE2 scale needed evaluation in a Tomsk adult population sample based on 5-year follow-up.
Does the SCORE2 scale accurately predict cardiovascular events in an urban adult population aged 40-64 years?
Population
971 people aged 40 to 64 years in Tomsk
Comparison
Cardiovascular risk stratification using clinical data, carotid ultrasound, and SCORE2
Design
Population-based cohort study
Follow-up
5-year follow-up
Key result
The SCORE2 scale classified 98% of relatively healthy individuals as high or very high risk, but their incidence of cardiovascular events was only 1% over 5 years (p=0.004).
Authors
Loading...
Clinical-anamnestic plus carotid ultrasound stratification captures most events; leaves open SCORE2 utility without local recalibration in Russian adults.
Cohort (n=971)
Does the SCORE2 scale accurately predict cardiovascular events in an urban adult population aged 40-64 years?
p-value: p=0.004
The SCORE2 scale significantly overestimated cardiovascular risk in a relatively healthy Russian cohort, classifying 98% as high or very high risk despite a 5-year event rate of only 1%.
Заирова et al. (2024) conducted a cohort in Cardiovascular risk (n=971). SCORE2 cardiovascular risk stratification was evaluated on Cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or stroke) (p=0.004). The SCORE2 scale classified 98% of relatively healthy individuals as high or very high risk, but their incidence of cardiovascular events was only 1% over 5 years (p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: